TORONTO, April 24 /CNW/ - The K2 Principal Fund L.P. ("K2") announced
that it has acquired 1,725,000 common shares of NeuroMedix Inc.
("NeuroMedix"). As a result of the acquisition of such shares, K2 owns
1,725,000 common shares representing approximately 10.83% of the issued and
outstanding common shares of NeuroMedix.
The common shares were purchased by K2 on the TSX Venture Exchange. K2
acquired the securities for investment purposes only and may, depending on
market and other conditions, increase or decrease its beneficial ownership,
control or direction over, or exercise its current rights to acquire, common
shares or other securities of NeuroMedix through market transactions, private
agreements or otherwise.
For further information:
For further information: Dan Gosselin, The K2 Principal Fund L.P., (416)